Scientific Sessions 2024  /  Featured Science: Incretin Modulation: Is a New Standard of Care Emerging?  /  Discussant: SUMMIT
Logo

American Heart Association

  9
  0

Final ID:

Discussant: SUMMIT

  • Lewis, Eldrin  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
    • Author Disclosures:
    Eldrin Lewis: DO have relevant financial relationships ; Consultant:Astra Zeneca:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Research Funding (PI or named investigator):American Heart Association:Active (exists now) ; Researcher:Idorsia:Active (exists now) ; Consultant:Intellia:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Akebia:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Incretin Modulation: Is a New Standard of Care Emerging?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Discussant: SUMMIT CMR

Kramer Chris, Rider Oliver, Wilcox Jane

Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status or Risk in the FLOW trial

Tuttle Katherine, Mann Johannes, Perkovic Vlado, Pratley Richard, Ridker Paul, Rossing Peter, Schmieder Roland, Shamkhalova Minara S., Sreenivasamurthy L, Mahaffey Kenneth, Bakris George, Bang Casper, Bax Willem, Belmar Nicolas, Brown Paul, Cherney David, Chernin Gil, Lim Soo Kun

More abstracts from these authors:
Navigating Leadership, Mentorship, and Sponsorship: A Personal Path to Professional Growth

Lewis Eldrin

Too Much Too Late: When to Forego Revascularization in Favor of Advanced Heart Failure Therapies

Pirlamarla Preethi, Lewis Eldrin, Uriel Nir

You have to be authorized to contact abstract author. Please, Login
Not Available